Tumor-associated fibroblast-conditioned medium promotes tumor cell proliferation and angiogenesis

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 5863-5871

  Xu, L N ^a   Xu, B N ^b   Cai, J ^a   Yang, J B ^a   Lin, N ^c  

^a THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Ovarian cancer cells; Transforming growth factor ; Tumor associated fibroblasts

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA ACTIN; CYCLINE; MESSENGER RNA; PROTEIN INHIBITOR; SB 431512; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALPHA SMOOTH MUSCLE ACTIN GENE; ANGIOGENESIS; ARTICLE; BETA ACTIN GENE; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; PARACRINE SIGNALING; PCNA GENE; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED FIBROBLAST; UPREGULATION; VASCULOTROPIN GENE;

ACTINS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FEMALE; FIBROBLASTS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888331301     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.November.22.14     Document Type: Article

References (23)

1. Agarwal A, Tressel SL, Kaimal R, Balla M, et al. (2010). Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy. Cancer Res. 70: 5880-5890.
2. Blobe GC, Schiemann WP and Lodish HF (2000). Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342: 1350-1358.
3. Cannistra SA (2004). Cancer of the ovary. N. Engl. J. Med. 351: 2519-2529.
4. Cirri P and Chiarugi P (2012). Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31: 195-208.
5. Drabsch Y and ten Dijke P (2011). TGF-beta signaling in breast cancer cell invasion and bone metastasis. J. Mammary Gland Biol. Neoplasia 16: 97-108.
6. Fuyuhiro Y, Yashiro M, Noda S, Kashiwagi S, et al. (2011). Upregulation of cancer-associated myofibroblasts by TGF-beta from scirrhous gastric carcinoma cells. Br. J. Cancer 105: 996-1001.
7. Galié M, Sorrention C, Montani M and Micossi L (2005). Mammary carcinoma provides highly tumorigenic and invasive reactive stromal cells. Carcinogenesis 26: 1868-1878.
8. Gatza CE, Holtzhausen A, Kirkbride KC, Morton A, et al. (2011). Type III TGF-beta receptor enhances colon cancer cell migration and anchorage-independent growth. Neoplasia 13: 758-770.
9. Jain RK, Lahdenranta J and Fukumura D (2008). Targeting PDGF signaling in carcinoma-associated fibroblasts controls cervical cancer in mouse model. PLoS Med. 5: e24.
10. Kiyono K, Suzuki HI, Matsuyama H, Morishita Y, et al. (2009). Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res. 69: 8844-8852.
11. Liotta LA and Kohn EC (2001). The microenvironment of the tumour-host interface. Nature 411: 375-379.
12. Mueller L, von Seggern L, Schumacher J, Goumas F, et al. (2010). TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts. Biochem. Biophys. Res. Commun. 397: 586-591.
13. Narine K, DeWever O, Cathenis K, Mareel M, et al. (2004). Transforming growth factor-beta-induced transition of fibroblasts: a model for myofibroblast procurement in tissue valve engineering. J. Heart Valve Dis. 13: 281-289.
14. Parrott JA, Nilsson E, Mosher R, Magrane G, et al. (2001). Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells. Mol. Cell. Endocrinol. 175: 29-39.
15. Raman D, Baugher PJ, Thu YM and Richmond A (2007). Role of chemokines in tumor growth. Cancer Lett. 256: 137-165.
16. Ribatti D and Vacca A (2008). The role of microenvironment in tumor angiogenesis. Genes Nutr. 3: 29-34.
17. Schmitt J and Matei D (2012). Targeting angiogenesis in ovarian cancer. Cancer Treat. Rev. 38: 272-283.
18. Schmitt-Graff A, Desmouliere A and Gabbiani G (1994). Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch. 425: 3-24.
19. Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, et al. (2008). Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. BMC Cancer 8: 364.
20. Terada T (2011). Ovarian malignant Mullerian mixed tumor (heterologous) whose epithelial component is composed predominantly of signet ring cell carcinoma. Arch. Gynecol. Obstet. 283: 1403-1406.
21. Xing F, Saidou J and Watabe K (2010). Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci. 15: 166-179.
22. Yan Z, Kim GY, Deng X and Friedman E (2002). Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. J. Biol. Chem. 277: 9870-9879.
23. Yu N, Kozlowski JM, Park II, Chen L, et al. (2010). Overexpression of transforming growth factor beta1 in malignant prostate cells is partly caused by a runaway of TGF-beta1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-beta type I receptor. Urology 76: 1513-1519.